# Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

> **NCT01212900** · PHASE4 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 230 (actual)

## Conditions studied

- Atherosclerosis
- Hypercholesterolemia

## Interventions

- **DRUG:** Statins, HMG CoA

## Key facts

- **NCT ID:** NCT01212900
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-30
- **Primary completion:** 2016-11-30
- **Final completion:** 2017-02-22
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2018-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212900, "Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01212900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*